Integrated Wealth Concepts LLC Cuts Position in The Clorox Company $CLX

Key Points

• Integrated Wealth Concepts LLC reduced its stake in The Clorox Company by 49.7% during Q1, holding 6,918 shares valued at approximately $1,019,000 after selling 6,838 shares.
• JPMorgan Chase & Co. increased its price target for Clorox from $133.00 to $135.00, while Barclays lowered it from $129.00 to $119.00, indicating mixed analyst sentiment towards the stock.
• The Clorox Company announced an increase in its quarterly dividend to $1.24 per share, reflecting a yield of 4.0% with a payout ratio of 76.07%.

Integrated Wealth Concepts LLC lowered its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 49.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,918 shares of the company's stock after selling 6,838 shares during the quarter. Integrated Wealth Concepts LLC's holdings in Clorox were worth $1,019,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Raymond James Financial Inc. increased its holdings in shares of Clorox by 15.6% during the first quarter. Raymond James Financial Inc. now owns 269,926 shares of the company's stock valued at $39,747,000 after acquiring an additional 36,352 shares in the last quarter. OneDigital Investment Advisors LLC acquired a new position in shares of Clorox during the first quarter valued at about $247,000. Brown Miller Wealth Management LLC acquired a new position in shares of Clorox during the first quarter valued at about $399,000. Roman Butler Fullerton & Co. acquired a new position in shares of Clorox during the first quarter valued at about $400,000. Finally, Wedge Capital Management L L P NC increased its holdings in shares of Clorox by 33.5% during the first quarter. Wedge Capital Management L L P NC now owns 28,510 shares of the company's stock valued at $4,198,000 after acquiring an additional 7,159 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on CLX shares. Barclays decreased their target price on Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a report on Tuesday, July 15th. UBS Group dropped their price target on Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a research report on Thursday, July 17th. Jefferies Financial Group dropped their price target on Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research report on Thursday, June 26th. Morgan Stanley lowered their price objective on Clorox from $150.00 to $137.00 and set an "equal weight" rating on the stock in a research note on Friday, August 1st. Finally, JPMorgan Chase & Co. upped their price target on Clorox from $133.00 to $135.00 and gave the company a "neutral" rating in a research note on Monday, September 8th. One equities research analyst has rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Reduce" and a consensus price target of $142.18.

Insider Buying and Selling

In other news, COO Eric H. Reynolds sold 15,041 shares of the business's stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares of the company's stock, valued at $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 0.57% of the company's stock.

Clorox Stock Up 0.5%

CLX traded up $0.56 on Wednesday, reaching $125.41. The company's stock had a trading volume of 1,301,466 shares, compared to its average volume of 1,777,791. The stock has a 50 day moving average of $124.21 and a two-hundred day moving average of $131.81. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The company has a market capitalization of $15.34 billion, a price-to-earnings ratio of 19.23, a P/E/G ratio of 1.00 and a beta of 0.52. The Clorox Company has a fifty-two week low of $116.53 and a fifty-two week high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping the consensus estimate of $2.24 by $0.63. The company had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm's revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be given a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a yield of 4.0%. The ex-dividend date is Wednesday, October 22nd. Clorox's payout ratio is presently 76.07%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.